Tau pathology in Alzheimer disease and other tauopathies

Iqbal, Khalid, del C. Alonso, Alejandra, Chen, She, Chohan, M. Omar, El-Akkad, Ezzat, Gong, Cheng-Xin, Khatoon, Sabiha, Li, Bin, Liu, Fei, Rahman, Abdur, Tanimukai, Hitoshi, Grundke-Iqbal, Inge·2005·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Cited by (999)

Items 301–400 of 999

  1. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins
    Véronique Schaeffer, Christine Patte‐Mensah, Anne Eckert, Ayikoe Guy Mensah‐Nyagan · 2006 · Journal of Neurobiology
  2. Genetics and dementia: Risk factors, diagnosis, and management
    Ging‐Yuek Robin Hsiung, Adele Dessa Sadovnick · 2007 · Alzheimer s & Dementia
  3. Mechanisms Underlying Neurodegenerative Disorders and Potential Neuroprotective Activity of Agrifood By-Products
    Cristina Angeloni, Marco Malaguti, Cecilia Prata, Michela Freschi, Maria Cristina Barbalace, Silvana Hrelia · 2022 · Antioxidants
  4. Transgenic models of Alzheimer's disease: Better utilization of existing models through viral transgenesis
    Thomas L Platt, Valerie L. Reeves, Michael Paul Murphy · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  5. Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases
    Maurizio Gasperi, Castellano Ae · 2010 · Journal of Endocrinological Investigation
  6. Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
    Mirjana Babić Leko, Dubravka Švob Štrac, Dorotea Mück‐Šeler, Nela Pivac, Gabrijela Stanić, Patrick R. Hof, Goran Šimić · 2014 · Croatian Medical Journal
  7. An effective treatment for Alzheimer's disease must consider both amyloid and tau
    Claire J. Lansdall · 2014 · Bioscience Horizons The International Journal of Student Research
  8. Alzheimer's disease: Is this a brain specific diabetic condition?
    Vanita Rani, Rahul R Deshmukh, Priya Jaswal, Puneet Kumar, Jitender B. Bariwal · 2016 · Physiology & Behavior
  9. A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1
    Testa, Gabriella, Staurenghi, Erica, Giannelli, Serena, Gargiulo, Simona, Guglielmotto, Michela, Tabaton, Massimo, Tamagno, Elena, Gamba, Paola, Leonarduzzi, Gabriella · 2018 · Redox Biology
  10. Role of calpain and caspase in β-amyloid-induced cell death in rat primary septal cultured neurons
    Zhiyun Wei, Mee-Sook Song, David MacTavish, Jack H. Jhamandas, Satyabrata Kar · 2007 · Neuropharmacology
  11. Alzheimers Disease - An Interactive Perspective
    Klaus Heese, Hiroyasu Akatsu · 2006 · Current Alzheimer Research
  12. CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease
    Roberto Ceravolo, Davide Borghetti, Lorenzo Kiferle, Gloria Tognoni, Assuero Giorgetti, Danilo Neglia, N. Sassi, Daniela Frosini, Carlo Alfonso Rossi, Lucia Petrozzi et al. · 2008 · Brain Research Bulletin
  13. Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease
    Patryk Pyka, Sabrina Garbo, Rossella Fioravanti, Claus Jacob, Marius Hittinger, Jadwiga Handzlik, Clemens Zwergel, Cecilia Battistelli · 2024 · Drug Discovery Today
  14. Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success
    Haruhiko Sugino, Akihito Watanabe, Naoki Amada, Miho Yamamoto, Yuta Ohgi, Dusan Kostic, Raymond Sanchez · 2015 · Clinical Therapeutics
  15. Genetic basis of Alzheimer's dementia: role of mtDNA mutations
    Manuela M. Grazina, J. Pratas, F. Silva, Sofia A. Oliveira, Isabel J. Santana, Catarina Resende Oliveira · 2006 · Genes Brain & Behavior
  16. Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease
    Spiegel, Jonathan, Pirraglia, Elizabeth, Osorio, Ricardo S., Glodzik, Lidia, Li, Yi, Tsui, Wai, Saint Louis, Leslie A., Randall, Catherine, Butler, Tracy, Xu, Jinfeng et al. · 2015 · Journal of Alzheimer's Disease
  17. Alzheimer’s disease, neural stem cells and neurogenesis: cellular phase at single-cell level
    Çağhan Kızıl, Mehmet İlyas Coşacak, Prabesh Bhattarai · 2019 · Neural Regeneration Research
  18. Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
    Giovanni Schepici, Serena Silvestro, Oriana Trubiani, Placido Bramanti, Emanuela Mazzon · 2020 · Brain Sciences
  19. Alterations in Tau Protein Level and Phosphorylation State in the Brain of the Autistic-Like Rats Induced by Prenatal Exposure to Valproic Acid
    Magdalena Gąssowska-Dobrowolska, Agnieszka Kolasa, Magdalena Cieślik, Agnieszka Dominiak, Kristina Friedland, Agata Adamczyk · 2021 · International Journal of Molecular Sciences
  20. Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.
    Zheng, Ping, Shultz, Sandy R., Hovens, Chris M., Velakoulis, Dennis, Jones, Nigel C., O’Brien, Terence J. · 2014 · Molecular Neurobiology
  21. Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects
    Yanke Yu, Veronika Logovinsky, Edgar L. Schuck, June M. Kaplow, Min‐Kun Chang, Takehiko Miyagawa, Nancy Wong, Jim Ferry · 2013 · The Journal of Clinical Pharmacology
  22. Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment
    Dantao Peng, Xiuqing Pan, Ju Cui, Yueqin Ren, Jiewen Zhang · 2013 · Cellular Physiology and Biochemistry
  23. Recent developments with tau-based drug discovery
    Khalid Iqbal, Fei Liu, Cheng‐Xin Gong · 2018 · Expert Opinion on Drug Discovery
  24. Tau in Oligodendrocytes Takes Neurons in Sickness and in Health
    Patrizia LoPresti · 2018 · International Journal of Molecular Sciences
  25. Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease
    Hind Muteb Albadrani, Payal Chauhan, Sumel Ashique, Marianesan Arockia Babu, Danish Iqbal, Abdulmajeed G. Almutary, Mosleh Mohammad Abomughaid, Mehnaz Kamal, Ana Cláudia Paiva‐Santos, Mohammed Alsaweed et al. · 2024 · Biomedicine & Pharmacotherapy
  26. Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
    Zaida L. Almeida, Daniela C. Vaz, Rui M. M. Brito · 2024 · Molecular Neurobiology
  27. Discrimination of Mild Cognitive Impairment and Alzheimer′s Disease Using Transfer Entropy Measures of Scalp EEG
    Joseph C. McBride, Xiaopeng Zhao, Nancy B. Munro, Gregory A. Jicha, Charles D. Smith, Yang Jiang · 2015 · Journal of Healthcare Engineering
  28. Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders
    Laura Kay, Ilse Sanet Pienaar, Ruwini Cooray, Gary W. Black, M. Soundararajan · 2018 · Molecular Neurobiology
  29. Physical Activity and Alzheimer’s Disease: A Narrative Review
    Piotr Gronek, Štefan Balkó, Joanna Gronek, Adam Zając, Adam Maszczyk, Roman Celka, Agnieszka Doberska, Wojciech Czarny, Robert Podstawski, Cain C. T. Clark et al. · 2019 · Aging and Disease
  30. Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage
    Isobel J. Whitehouse, James Scott Miners, Elizabeth B. C. Glennon, Patrick G. Kehoe, Seth Love, Katherine A. B. Kellett, Nigel M. Hooper · 2013 · PLoS ONE
  31. Safflower yellow reduces lipid peroxidation, neuropathology, tau phosphorylation and ameliorates amyloid β-induced impairment of learning and memory in rats
    Qin Ma, Yingying Ruan, Hui Ying Xu, Xiaomeng Shi, Zhixiang Wang, Yanli Hu · 2015 · Biomedicine & Pharmacotherapy
  32. Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer’s disease
    Silva, Aderbal R. T., Grinberg, Lea T., Farfel, Jose M., Diniz, Breno S., Lima, Leandro A., Silva, Paulo J. S., Ferretti, Renata E. L., Rocha, Rafael M., Filho, Wilson Jacob, Carraro, Dirce M. et al. · 2012 · PLoS ONE
  33. PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau
    Abdur Rahman, Inge Grundke, Khalid Iqbal · 2005 · Journal of Neural Transmission
  34. Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease
    Yan Jin, Parul Singh, Hea‐Jong Chung · 2018 · Nutrients
  35. Potential of Sorghum Polyphenols to Prevent and Treat Alzheimer’s Disease: A Review Article
    Nasim Rezaee, Warnakulasuriya Mary Ann Dipika Binosha Fernando, Eugene Hone, Hamid Reza Sohrabi, Stuart Keith Johnson, Stuart T. Gunzburg, Ralph Nigel Martins · 2021 · Frontiers in Aging Neuroscience
  36. Correlation between Choline Signal Intensity and Acetylcholine Level in Different Brain Regions of Rat
    Xiaochuan Wang, Xiaoxia Du, Qing Tian, Jian‐Zhi Wang · 2007 · Neurochemical Research
  37. Developing pharmacological therapies for Alzheimer disease
    Khalid Iqbal, Inge Grundke · 2007 · Cellular and Molecular Life Sciences
  38. Partial deletion of theMAPTgene: A novel mechanism of FTDP-17
    Anne Rovelet‐Lecrux, Magalie Lecourtois, Catherine Thomas-Antérion, Isabelle Le Ber, Alexis Brice, Thierry Frébourg, Didier Hannequin, Dominique Campion · 2009 · Human Mutation
  39. Pseudohyperphosphorylation Has Differential Effects on Polymerization and Function of Tau Isoforms
    Combs, Benjamin, Voss, Kellen, Gamblin, T. Chris · 2011 · Biochemistry
  40. Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease
    Shen Ning, Mehdi Jorfi, Shaun R. Patel, Doo Yeon Kim, Rudolph E. Tanzi · 2022 · Frontiers in Neuroscience
  41. Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein
    Te‐Hsien Lin, Kuo‐Hsuan Chang, Ya‐Jen Chiu, Zheng-Kui Weng, Ying‐Chieh Sun, Wenwei Lin, Guey‐Jen Lee‐Chen, Chiung‐Mei Chen · 2022 · International Journal of Molecular Sciences
  42. Female Hippocampus Vulnerability to Environmental Stress, a Precipitating Factor in Tau Aggregation Pathology
    Ioannis Sotiropoulos, Joana Margarida Silva, Tetsuya Kimura, Ana João Rodrigues, Patrí­cio Costa, Osborne F. X. Almeida, Nuno Sousa, Akihiko Takashima · 2014 · Journal of Alzheimer s Disease
  43. A peptidyl–prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles
    Hisato Sugata, Kazuhiko Matsuo, Taisuke Nakagawa, Mikiko Takahashi, Hideyuki Mukai, Yoshitaka Ono, Kiyoshi Maeda, Haruhiko Akiyama, Toshio Kawamata · 2009 · Neuroscience Letters
  44. Inhibition of Phosphorylation of JNK Suppresses Aβ-Induced ER Stress and Upregulates Prosurvival Mitochondrial Proteins in Rat Hippocampus
    Parvin Yenki, Fariba Khodagholi, Fatemeh Shaerzadeh · 2012 · Journal of Molecular Neuroscience
  45. Flavones 7,8-DHF, Quercetin, and Apigenin Against Tau Toxicity via Activation of TRKB Signaling in ΔK280 TauRD-DsRed SH-SY5Y Cells
    Ni-Ni Chiang, Te‐Hsien Lin, Yu-Shan Teng, Ying‐Chieh Sun, Kuo‐Hsuan Chang, Chung‐Yin Lin, Hsiu Mei Hsieh‐Li, Ming‐Tsan Su, Chiung‐Mei Chen, Guey‐Jen Lee‐Chen · 2021 · Frontiers in Aging Neuroscience
  46. Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
    Rita Azevedo, Chloé Jacquemin, Nicolas Villain, François Fenaille, Foudil Lamari, François Bécher · 2022 · Cells
  47. Phosphorylation of FTDP-17 Mutant tau by Cyclin-dependent Kinase 5 Complexed with p35, p25, or p39
    Fumika Sakaue, Taro Saito, Yutaka Satō, Akiko Asada, Koichi Ishiguro, Masato Hasegawa, Shin‐ichi Hisanaga · 2005 · Journal of Biological Chemistry
  48. Intracellular Degradation of Misfolded Tau Protein Induced by Geldanamycin is Associated with Activation of Proteasome
    Alena Opattová, Peter Filipčík, Martin Cente, Michal Novák · 2012 · Journal of Alzheimer s Disease
  49. Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
    Hannah Rickner, Lulu Jiang, Rui Hong, Nicholas K. O’Neill, Chromewell A. Mojica, Benjamin J. Snyder, Lushuang Zhang, Dipan Shaw, Maria Medalla, Benjamin L. Wolozin et al. · 2022 · Nature Communications
  50. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP‐17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer’s disease
    Anna-Maria Shiarli, Rachel E. Jennings, J. Shi, Kathryn L. Bailey, Yvonne S. Davidson, Jinzhou Tian, Eileen H. Bigio, Bernardino Francesco Ghetti, Jill R. Murrell, Marie‐Bernadette Delisle et al. · 2006 · Neuropathology and Applied Neurobiology
  51. Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro
    Han, Dong, Qureshi, Hamid Y., Lu, Yifan, Paudel, Hemant K. · 2009 · Journal of Biological Chemistry
  52. Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease
    Feng, Shu, Liu, Yongzhen, Zhou, Yu, Shu, Zhenfeng, Cheng, Zhuxi, Brenner, Charles, Feng, Pinghui · 2023 · Frontiers in Aging Neuroscience
  53. Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease.
    Hakimeh Zali, Mona Zamanian Azodi, Mostafa Rezaei–Tavirani, Alireza Akbarzadeh Baghban · 2015 · Europe PMC (PubMed Central)
  54. Tau Protein Phosphorylation in Diverse Brain Areas of Normal and CRH Deficient Mice: Up-Regulation by Stress
    Peter Filipčík, Petr Novák, Boris Mravec, Katarína Ondičová, Gabriela Krajciova, Michal Novák, Richard Květňanský · 2012 · Cellular and Molecular Neurobiology
  55. Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
    Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh · 2020 · Biology
  56. Genetic deletion of α7 nicotinic acetylcholine receptors induces an age-dependent Alzheimer’s disease-like pathology
    Maria Rosaria Tropea, Domenica Donatella Li Puma, Marcello Melone, Walter Gulisano, Ottavio Arancio, Claudio Grassi, Fiorenzo Conti, Daniela Puzzo · 2021 · Progress in Neurobiology
  57. Phlorotannin-rich Ecklonia cava reduces the production of beta-amyloid by modulating alpha- and gamma-secretase expression and activity
    Il‐Jun Kang, Bong Geom Jang, Sua In, Boyoung Choi, Misook Kim, Min-Ju Kim · 2012 · NeuroToxicology
  58. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies
    Kiren K. Ubhi, Hassan Shaibah, Tracey A. Newman, David Shepherd, Amritpal K. Mudher · 2007 · Invertebrate Neuroscience
  59. Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer’s disease: do we need new inhibitors?
    David Henry Small · 2005 · Expert Opinion on Emerging Drugs
  60. Effect and Mechanism of Acupuncture on Alzheimer’s Disease
    Bai‐Yun Zeng, Sarah Salvage, Peter G. Jenner · 2013 · International review of neurobiology
  61. Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy
    Chelsey Jenna LeBlang, Maria Medalla, Nicholas William Nicoletti, Emma Catherine Hays, James Zhao, Jenifer E. Shattuck, Anna Lourdes Cruz, Benjamin L. Wolozin, Jennifer Irene Luebke · 2020 · Frontiers in Neuroscience
  62. Golgi fragmentation – One of the earliest organelle phenotypes in Alzheimer’s disease neurons
    Henriette Haukedal, Giulia Ilaria Corsi, Veerendra P. Gadekar, Nadezhda T. Doncheva, Shekhar Kedia, Noortje de Haan, Abinaya Chandrasekaran, Pia Jensen, Pernille Schiønning, Sarah Vallin et al. · 2023 · Frontiers in Neuroscience
  63. Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook
    Amy L. Vāvere, Peter J. H. Scott · 2017 · Seminars in Nuclear Medicine
  64. Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease
    Madhuri Chakravarthy, Suxiang Chen, Peter Ronald Dodd, Rakesh Naduvile Veedu · 2017 · Theranostics
  65. Recent advances in phosphoproteomics and application to neurological diseases
    Justine V. Arrington, Chuan‐Chih Hsu, Sarah G. Elder, W. Andy Tao · 2017 · The Analyst
  66. Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis
    Morteza Abyadeh, Kurosh Djafarian, Fatemeh Heydarinejad, Shahab Alizadeh, Sakineh Shab‐Bidar · 2019 · Journal of Molecular Neuroscience
  67. Selection of a D-Enantiomeric Peptide Specifically Binding to PHF6 for Inhibiting Tau Aggregation in Transgenic Mice
    Xiancheng Zhang, Xiaoyu Zhang, Manli Zhong, Pu Zhao, Chuang Guo, You Li, Tao Wang, Huiling Gao · 2020 · ACS Chemical Neuroscience
  68. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders
    Fabio Di Domenico, Chiara Lanzillotta · 2022 · Advances in protein chemistry and structural biology
  69. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease
    Craig Atwood, Richard L. Bowen · 2015 · Hormones and Behavior
  70. Basis for MAP4 Dephosphorylation-related Microtubule Network Densification in Pressure Overload Cardiac Hypertrophy
    Guangmao Cheng, Masaru Takahashi, Anandakumar Shunmugavel, J. Grace Wallenborn, Anna A DePaoli-Roach, Ulrich Gergs, Joachim Neumann, Dhandapani Kuppuswamy, Donald R. Menick, George Cooper · 2010 · Journal of Biological Chemistry
  71. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease
    Al-Atrache, Zein, Lopez, Danielle B., Hingley, Susan T., Appelt, Denah M. · 2019 · BMC Neuroscience
  72. Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer’s disease patients
    Maria Sen Mun Wai, Yong Liang, Chun Shi, Eric Yu Pang Cho, Hsiang‐Fu Kung, David Tai Wai Yew · 2008 · Biogerontology
  73. Melatonin arrests peroxynitrite‐induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain
    Jun Yin, Yinghua Liu, Yafei Xu, Yongjie Zhang, Jianguo Chen, Baihua Shu, Jian‐Zhi Wang · 2006 · Journal of Pineal Research
  74. Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease
    Nanjundaiah, Shwetha, Chidambaram, Hariharakrishnan, Chandrashekar, Madhura, Chinnathambi, Subashchandrabose · 2021 · Cellular and Molecular Neurobiology
  75. Overactivation of NR 2B‐containing NMDA receptors through entorhinal–hippocampal connection initiates accumulation of hyperphosphorylated tau in rat hippocampus after transient middle cerebral artery occlusion
    Chengshi Xu, An‐Chun Liu, Juan Chen, Zhi‐Yong Pan, Qi Wan, Zhiqiang Li, Ze‐Fen Wang · 2015 · Journal of Neurochemistry
  76. The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease
    Robert I. Richards, Sarah Anne Robertson, Louise V. O’Keefe, Dani L Fornarino, Andrew Scott, Michael T. Lardelli, Bernhard Theodor Baune · 2016 · Frontiers in Neuroscience
  77. Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease
    Simon Gelman, Jonathan D. Palma, Geoffrey C. Tombaugh, Afshin Ghavami · 2017 · Journal of Alzheimer s Disease
  78. Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
    Hasan A. M. M. Almansoub, Hui Ru Tang, Ying Wu, Ding‐Qi Wang, Yacoubou Abdoul Razak Mahaman, Na Wei, Yusra A. M. Almansob, Wei He, Dan Liu · 2018 · Journal of Alzheimer s Disease
  79. Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
    Jianlan Gu, Fei Liu · 2020 · Current Medical Science
  80. Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
    Serena Silvestro, Andrea Valeri, Emanuela Mazzon · 2022 · International Journal of Molecular Sciences
  81. 14-3-3 proteins and protein phosphatases are not reduced in tau-deficient mice
    Katsunori Fujio, Mahito Sato, Takefumi Uemura, Takashi Sato, Reiko Sato-Harada, Akihiro Harada · 2007 · Neuroreport
  82. Ellagic acid ameliorates learning and memory impairment in APP/PS1 transgenic mice via inhibition of β‑amyloid production and tau hyperphosphorylation
    Lili Zhong, Hong Liu, Weijia Zhang, Xu Liu, Bo Jiang, Hongxin Fei, Zhongren Sun · 2018 · Experimental and Therapeutic Medicine
  83. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease
    Kemeng Pan, Song Chen, Yue Wang, Wenbing Yao, Xiangdong Gao · 2021 · Neuropharmacology
  84. Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease
    Kyoka Hoshi, Hiromi Ito, Eriko Abe, Takashi J. Fuwa, Mayumi Kanno, Yuta Murakami, Mitsunari Abe, Takenobu Murakami, Akioh Yoshihara, Yoshikazu Ugawa et al. · 2021 · Metabolites
  85. Tauons and Prions: Infamous Cousins?
    Petr Novák, Michal Prčina, Eva Kontseková · 2011 · Journal of Alzheimer s Disease
  86. Effect of phosphorylation on interaction of human tau protein with 14-3-3ζ
    Nikolai N. Sluchanko, Alim S. Seit‐Nebi, Nikolai B. Gusev · 2009 · Biochemical and Biophysical Research Communications
  87. Conformational Sampling with Implicit Solvent Models: Application to the PHF6 Peptide in Tau Protein
    Austin Huang, Collin M. Stultz · 2006 · Biophysical Journal
  88. A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick’s Disease and Fronto-Temporal Tauopathies
    Edward M. Rockenstein, Cassia Overk, Kiren K. Ubhi, Michael Mante, Christina Patrick, Anthony Adame, Alejandro Bisquert, Margarita Trejo, Brian J. Spencer, Eliezer Masliah · 2015 · PLoS ONE · Retracted
  89. FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation
    Xiu-Qi Bao, Ning Li, Tao Wang, Xiangchen Kong, Wenjiao Tai, Hua Sun, Dan Zhang · 2013 · PLoS ONE
  90. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration
    Alejandra Martínez-Maldonado, Miguel Ángel Ontiveros‐Torres, Charles R. Harrington, José Francisco Montiel-Sosa, Raúl García-Tapia Prandiz, Alma Patricia Bocanegra-López, Andrew Michael Sorsby-Vargas, Marely Bravo-Muñoz, Benjamí­n Florán, Ignacio Villanueva‐Fierro et al. · 2021 · Journal of Alzheimer s Disease
  91. Synthesis, Computational Pharmacokinetics Report, Conceptual DFT-Based Calculations and Anti-Acetylcholinesterase Activity of Hydroxyapatite Nanoparticles Derived From Acorus Calamus Plant Extract
    Sushma Pradeep, Anisha S Jain, Chandan Dharmashekara, Shashanka K. Prasad, Nagaraju Akshatha, R. Pruthvish, Raghavendra G G Amachawadi, Chandrashekar Srinivasa, Asad Syed, Abdallah Mohamed Elgorban et al. · 2021 · Frontiers in Chemistry
  92. Effect of chronic noise exposure on expression of N-methyl-D-aspartic acid receptor 2B and Tau phosphorylation in hippocampus of rats.
    Bo Cui, Ming Quan Wu, Li Xing Zhu, Xiao Jun She, Qiang Ma, Hong Tao Liu · 2013 · PubMed
  93. Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro
    Robert A. Whittington, László Virág, Maud Gratuze, Franck R. Petry, Anastasia Noël, Isabelle Poitras, Geoffrey Truchetti, François Marcouiller, Marie-Amélie Papon, Noura B. El Khoury et al. · 2015 · Neurobiology of Aging
  94. Inhibition of β-amyloid1-42 internalization attenuates neuronal death by stabilizing the endosomal-lysosomal system in rat cortical cultured neurons
    Mee-Sook Song, Glen B. Baker, Kathryn G. Todd, Satyabrata Kar · 2011 · Neuroscience
  95. Berberine Attenuates Axonal Transport Impairment and Axonopathy Induced by Calyculin A in N2a Cells
    Xiaofeng Liu, Jie Zhou, Morad Dirhem Naji Abid, Huanhuan Yan, Hao Huang, Limin Wan, Zuo‐Hua Feng, Juan Chen · 2014 · PLoS ONE
  96. Site-specific Microtubule-associated Protein 4 Dephosphorylation Causes Microtubule Network Densification in Pressure Overload Cardiac Hypertrophy
    Chinnakkannu Panneerselvam, Venkatesababa Samanna, Guangmao Cheng, Zsolt Ablonczy, Catalin F. Baicu, Jennifer Rutherford Bethard, Donald R. Menick, Dhandapani Kuppuswamy, George Cooper · 2010 · Journal of Biological Chemistry
  97. MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
    Ivana Raffaele, Serena Silvestro, Emanuela Mazzon · 2023 · International Journal of Molecular Sciences
  98. GSK-3β phosphorylation of functionally distinct tau isoforms has differential, but mild effects
    Kellen Voss, T.C. Gamblin · 2009 · Molecular Neurodegeneration
  99. Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction
    Kristina V. Tugaeva, Philipp O. Tsvetkov, Nikolai N. Sluchanko · 2017 · PLoS ONE
  100. Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer’s disease: A review on experimental progress and computational modeling
    Jingyi Liang, Don Kulasiri, Sandhya Samarasinghe · 2015 · Biosystems